‌

US Patent 11643404 Ester substituted ion channel blockers and methods for use

Patent 11643404 was granted and assigned to Nocion Therapeutics on May, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Nocion Therapeutics

0

Current Assignee

Nocion Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bridget McCarthy Cole0

James Lamond Ellis0

Date of Patent

May 9, 2023

0

Patent Application Number

169528630

Date Filed

November 19, 2020

0

Patent Citations

US Patent 10925865 Charged ion channel blockers and methods for use

0

US Patent 10927096 Ester substituted ion channel blockers and methods for use

0

US Patent 10933055 Charged ion channel blockers and methods for use

0

US Patent 10934263 Charged ion channel blockers and methods for use

0

US Patent 10968179 Charged ion channel blockers and methods for use

0

US Patent 11377422 Charged ion channel blockers and methods for use

0

US Patent 10179116 Methods, compositions, and kits for treating pain and pruritis

0

US Patent 10525143 Conjugate of polyethylene glycol and anesthetic, and preparation method thereof

0

...

Patent Primary Examiner

Brenda L Coleman

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11643404 Ester substituted ion channel blockers and methods for use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.